COMMUNIQUÉS West-GlobeNewswire

Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
18/12/2025
Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) ( [...]
AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
18/12/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE INITIATION OF COVERAGE OF ITS STOCK BY MAXIM GROUP WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, December 18, 2025, 7.15pm CET AB Science SA (Euronext - FR0010557264 - AB) [...]
AB Science annonce l’initiation de la couverture de son titre par Maxim Group avec un objectif de cours de 4,0 euros par action
18/12/2025
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE L’INITIATION DE LA COUVERTURE DE SON TITRE PAR MAXIM GROUP AVEC UN OBJECTIF DE COURS DE 4,0 EUROS PAR ACTION Paris, le 18 décembre 2025, 19h15 CET AB Science SA (Euronext - [...]
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
18/12/2025
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® Kit TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical [...]
CARBIOS maintains its commitment to build the Longlaville plant and adjusts its timeline
18/12/2025
CARBIOS reaffirms its ambition to pursue the Longlaville plant construction project and postpones the timeline by three-month. The plant construction project is supported by: Pre-commercialization contracts covering [...]
CARBIOS maintient son objectif de construction de l’usine de Longlaville avec un calendrier ajusté
18/12/2025
CARBIOS réaffirme son ambition de poursuivre le projet de construction de l’usine à Longlaville en décalant le calendrier prévisionnel de trois mois. Le projet de construction de l’usine est aujourd’hui conforté par : [...]
NeuExcell Therapeutics Reports Encouraging Clinical Results with World’s First In Situ Conversion Therapy for Malignant Glioma
18/12/2025
SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- NeuExcell Therapeutics announced encouraging clinical results of NXL-004, the world’s first in situ conversion gene therapy for malignant glioma. The data were presented at [...]
Crucial Innovations Retains FOCUS Capital Partners to Support Strategic Growth and Investment Initiatives
18/12/2025
LONDON, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crucial Innovations Corp . (“CINV” or “the Company”), an international pioneering medical cannabis company, announced that it has formally retained FOCUS Capital Partners (“ [...]
Therapy for Women Joins the Lumina Therapy Alliance, Strengthening a National Network Serving Employers and Their Workforces
18/12/2025
Broadening national access to in-person care, with specialized expertise supporting women in high-performance workplaces NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lumina Therapy Alliance , the nation’s leading [...]
J-Star Announces Interim Financial Results for the First Six Months of 2025
18/12/2025
TAICHUNG CITY, Taiwan, Dec. 18, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of [...]
Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
18/12/2025
-- Innovative single-device solution integrates proven FemVue and FemChec ® technologies to support fallopian tube evaluation and improve workflow efficiency-- ATLANTA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. ( [...]
SafeSpace Global Enters Letter of Intent with BMRT for Exclusive Deployment of Molecular-Level Weapons Detection Technology in U.S. Schools and Correctional Facilities
18/12/2025
Letter of Intent Contemplates Joint Venture and Exclusive Deployment Rights Across Estimated $6 Billion Addressable Market Knoxville, TN, Dec. 18, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:SSGC) (“ [...]
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference
18/12/2025
- The overview presentation will review some of the Company’s recent achievements as well as the outlook for upcoming data milestones - JERUSALEM, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", [...]
ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK
18/12/2025
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® Kit TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical [...]
TOMI Environmental Solutions Secures a Purchase Order of Approximately $500,000 for the Integration of SteraMist iHP Technology within a Global Biopharmaceutical Leader
18/12/2025
FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today announced it has received a [...]
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
18/12/2025
BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a biotech company focused on advancing cancer treatments, today announced that it has entered into [...]
Coloplast announces changes to Executive Leadership Team
18/12/2025
Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate to the company’s Interventional Urology business as well as the global People & Culture function. Executive [...]
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants
18/12/2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“ [...]
Actuate Therapeutics Phase 2 Metastatic Pancreatic Cancer Data Selected for Oral and Poster Presentation at ASCO GI 2026
18/12/2025
CHICAGO and FORT WORTH, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the [...]

Pages